Drugs for Non-small Cell Lung Cancer

Global Drugs for Non-small Cell Lung Cancer Market Data Survey Report 2013-2025

Report ID: HeyReport 18831 | Number of pages: 104 | Publish Date: Mar 2019 | Category: Lifesciences and Healthcare
Summary
The global Drugs for Non-small Cell Lung Cancer market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
    Bristol-Myers Squibb 
    GlaxoSmithKline 
    Menarini 
    Sanofi 
    Ziopharm Oncology 
    Alchemia 
    Amgen 
    Apotex 
    BioMarin Pharmaceutical 
    CellAct Pharma 
    Cerulean Pharma 
    Cipla 
    Cornerstone Pharmaceuticals 
    Curis 
    CytRx 
    Eli Lilly 
    Exelixis 
    Fresenius Kabi 
    Genentech 
    Hikma Pharmaceuticals 
    Hospira 
    Intas Pharmaceuticals 
    Karyopharm Therapeutics 
    Kyowa Hakko Kirin 
    Ligand Pharmaceuticals
Major applications as follows:
    Hospital 
    Clinic 
    Others
Major Type as follows:
    Radiofrequency Ablation (RFA) 
    Radiation Therapy 
    Chemotherapy 
    Targeted Therapies 
    Immunotherapy
Regional market size, production data and export & import:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa
Interested in this report?
Get your sample now!
Table of Contents
1 Global Market Overview
    1.1 Scope of Statistics
        1.1.1 Scope of Products
        1.1.2 Scope of Manufacturers
        1.1.3 Scope of Application
        1.1.4 Scope of Type
        1.1.5 Scope of Regions/Countries
    1.2 Global Market Size
2 Regional Market
    2.1 Regional Production
    2.2 Regional Demand
    2.3 Regional Trade
3 Key Manufacturers
    3.1 Bristol-Myers Squibb 
        3.1.1 Company Information
        3.1.2 Product & Services
        3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.1.4 Recent Development
    3.2 GlaxoSmithKline 
        3.2.1 Company Information
        3.2.2 Product & Services
        3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.2.4 Recent Development
    3.3 Menarini 
        3.3.1 Company Information
        3.3.2 Product & Services
        3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.3.4 Recent Development
    3.4 Sanofi 
        3.4.1 Company Information
        3.4.2 Product & Services
        3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.4.4 Recent Development
    3.5 Ziopharm Oncology 
        3.5.1 Company Information
        3.5.2 Product & Services
        3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.5.4 Recent Development
    3.6 Alchemia 
        3.6.1 Company Information
        3.6.2 Product & Services
        3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.6.4 Recent Development
    3.7 Amgen 
        3.7.1 Company Information
        3.7.2 Product & Services
        3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.7.4 Recent Development
    3.8 Apotex 
        3.8.1 Company Information
        3.8.2 Product & Services
        3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.8.4 Recent Development
    3.9 BioMarin Pharmaceutical 
        3.9.1 Company Information
        3.9.2 Product & Services
        3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.9.4 Recent Development
    3.10 CellAct Pharma 
        3.10.1 Company Information
        3.10.2 Product & Services
        3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.10.4 Recent Development
    3.11 Cerulean Pharma 
        3.11.1 Company Information
        3.11.2 Product & Services
        3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.11.4 Recent Development
    3.12 Cipla 
        3.12.1 Company Information
        3.12.2 Product & Services
        3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.12.4 Recent Development
    3.13 Cornerstone Pharmaceuticals 
        3.13.1 Company Information
        3.13.2 Product & Services
        3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.13.4 Recent Development
    3.14 Curis 
        3.14.1 Company Information
        3.14.2 Product & Services
        3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.14.4 Recent Development
    3.15 CytRx 
        3.15.1 Company Information
        3.15.2 Product & Services
        3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.15.4 Recent Development
    3.16 Eli Lilly 
        3.16.1 Company Information
        3.16.2 Product & Services
        3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.16.4 Recent Development
    3.17 Exelixis 
        3.17.1 Company Information
        3.17.2 Product & Services
        3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.17.4 Recent Development
    3.18 Fresenius Kabi 
        3.18.1 Company Information
        3.18.2 Product & Services
        3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.18.4 Recent Development
    3.19 Genentech 
        3.19.1 Company Information
        3.19.2 Product & Services
        3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.19.4 Recent Development
    3.20 Hikma Pharmaceuticals 
        3.20.1 Company Information
        3.20.2 Product & Services
        3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.20.4 Recent Development
    3.21 Hospira 
        3.21.1 Company Information
        3.21.2 Product & Services
        3.21.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.21.4 Recent Development
    3.22 Intas Pharmaceuticals 
        3.22.1 Company Information
        3.22.2 Product & Services
        3.22.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.22.4 Recent Development
    3.23 Karyopharm Therapeutics 
        3.23.1 Company Information
        3.23.2 Product & Services
        3.23.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.23.4 Recent Development
    3.24 Kyowa Hakko Kirin 
        3.24.1 Company Information
        3.24.2 Product & Services
        3.24.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    3.25 Ligand Pharmaceuticals
        3.25.1 Company Information
        3.25.2 Product & Services
        3.25.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
    4.1 Hospital 
        4.1.1 Overview
        4.1.2 Hospital  Market Size and Forecast
    4.2 Clinic 
        4.2.1 Overview
        4.2.2 Clinic  Market Size and Forecast
    4.3 Others
        4.3.1 Overview
        4.3.2 Others Market Size and Forecast
5 Market by Type
    5.By Radiofrequency Ablation (RFA) 
    5.1 Radiofrequency Ablation (RFA) 
        5.1.1 Overview
        5.1.2 Radiofrequency Ablation (RFA)  Market Size and Forecast
    5.2 Radiation Therapy 
        5.2.1 Overview
        5.2.2 Radiation Therapy  Market Size and Forecast
    5.3 Chemotherapy 
        5.3.1 Overview
        5.3.2 Chemotherapy  Market Size and Forecast
    5.4 Targeted Therapies 
        5.4.1 Overview
        5.4.2 Targeted Therapies  Market Size and Forecast
    5.5 Immunotherapy
        5.5.1 Overview
        5.5.2 Immunotherapy Market Size and Forecast
6 Price Overview
    6.1 Price by Manufacturers
    6.2 Price by Application
    6.3 Price by Type
7 Conclusion
Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Menarini 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sanofi 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Ziopharm Oncology 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Alchemia 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Amgen 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Apotex 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of BioMarin Pharmaceutical 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of CellAct Pharma 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Cerulean Pharma 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Cipla 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Cornerstone Pharmaceuticals 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Curis 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of CytRx 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eli Lilly 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Exelixis 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Fresenius Kabi 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Genentech 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Hikma Pharmaceuticals 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Hospira 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Intas Pharmaceuticals 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Karyopharm Therapeutics 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Kyowa Hakko Kirin 
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Ligand Pharmaceuticals
Fig Global Drugs for Non-small Cell Lung Cancer Market Size and CAGR 2013-2018 (Million USD)
Fig Global Drugs for Non-small Cell Lung Cancer Market Size and CAGR 2013-2018 (Volume)
Fig Global Drugs for Non-small Cell Lung Cancer Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Drugs for Non-small Cell Lung Cancer Market Forecast and CAGR 2019-2025 (Volume)
Fig Hospital  Market Size and CAGR 2013-2018 (Million USD)
Fig Hospital  Market Size and CAGR 2013-2018 (Volume)
Fig Hospital  Market Forecast and CAGR 2019-2025 (Million USD)
Fig Hospital  Market Forecast and CAGR 2019-2025 (Volume)
Fig Clinic  Market Size and CAGR 2013-2018 (Million USD)
Fig Clinic  Market Size and CAGR 2013-2018 (Volume)
Fig Clinic  Market Forecast and CAGR 2019-2025 (Million USD)
Fig Clinic  Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Fig Radiofrequency Ablation (RFA)  Market Size and CAGR 2013-2018 (Million USD)
Fig Radiofrequency Ablation (RFA)  Market Size and CAGR 2013-2018 (Volume)
Fig Radiofrequency Ablation (RFA)  Market Forecast and CAGR 2019-2025 (Million USD)
Fig Radiofrequency Ablation (RFA)  Market Forecast and CAGR 2019-2025 (Volume)
Fig Radiation Therapy  Market Size and CAGR 2013-2018 (Million USD)
Fig Radiation Therapy  Market Size and CAGR 2013-2018 (Volume)
Fig Radiation Therapy  Market Forecast and CAGR 2019-2025 (Million USD)
Fig Radiation Therapy  Market Forecast and CAGR 2019-2025 (Volume)
Fig Chemotherapy  Market Size and CAGR 2013-2018 (Million USD)
Fig Chemotherapy  Market Size and CAGR 2013-2018 (Volume)
Fig Chemotherapy  Market Forecast and CAGR 2019-2025 (Million USD)
Fig Chemotherapy  Market Forecast and CAGR 2019-2025 (Volume)
Fig Targeted Therapies  Market Size and CAGR 2013-2018 (Million USD)
Fig Targeted Therapies  Market Size and CAGR 2013-2018 (Volume)
Fig Targeted Therapies  Market Forecast and CAGR 2019-2025 (Million USD)
Fig Targeted Therapies  Market Forecast and CAGR 2019-2025 (Volume)
Fig Immunotherapy Market Size and CAGR 2013-2018 (Million USD)
Fig Immunotherapy Market Size and CAGR 2013-2018 (Volume)
Fig Immunotherapy Market Forecast and CAGR 2019-2025 (Million USD)
Fig Immunotherapy Market Forecast and CAGR 2019-2025 (Volume)